Atlas Trials

Ambrx, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ambrx, Inc.

RecordFirmDate
ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02) (NCT05041972)Ambrx, Inc.2021-11-05
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) (NCT04829604)Ambrx, Inc.2021-10-26
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01) (NCT03255070)Ambrx, Inc.2018-03-20

Track Ambrx, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.